PEAK6 Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

PEAK6 Investments’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,376	Closed	-$37K	–	4627
2019 Q1	$37K	Buy	+6,376	New	+$65.8K	﹤0.01%	3474

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Investments's DPLO Position: Q2 2019 in Review

PEAK6 Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 6,376 shares — an estimated $37K sold.

PEAK6 Investments first reported a position in DPLO in Q1 2019 and held it in 1 quarter. The position peaked at $37K in Q1 2019. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

PEAK6 Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
PEAK6 Investments sold 6,376 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $37K.
PEAK6 Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2019 and held it in 1 quarter.
PEAK6 Investments's DIPLOMAT PHARMACY, INC. position peaked at $37K in Q1 2019.
131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on PEAK6 Investments's 13F filing for Q2 2019, filed 14 Aug 2019.